Workshop Learning Objectives 2019-02-25T02:19:53+00:00

Workshop Learning Objectives

Wednesday, February 27, 2019

CRA Indigenous Health Initiative – Lynden Crowshoe

First delivered in 2018, the Board of Directors of the CRA has approved a second session of this ‘Train the Trainer’ Indigenous Health Initiative for 2019. We have planned a series of interactive and in-depth educational opportunities, based on an evidence-based continuing medical education program, ‘Educating for Equity (E4E)’, to build practice capabilities in Indigenous Health.

At the end of this session, participants will be able to:

  1. explore concepts of the Educating for Equity Framework
  2. demonstrate chronic disease management that engages with key social factors facilitated by culturally informed approaches to supporting patients
  3. demonstrate therapeutic relationship building that incorporates culturally attuned approaches and address discord arising from health care inequity

CanMEDS roles

  1. Communicator
  2. Collaborator
  3. Leader
  4. Health Advocate
  5. Professional

Thursday, February 28, 2019

How to Advocate for Better Rheumatology Care – Andre Picard

In this interactive session, a veteran journalist offers practical tips for advocating for better patient care, including access to drug therapies.

At the end of this session, participants will be able to:

  1. discuss the role of the media in the dissemination of health research
  2. reflect on the importance of health/science communication
  3. enhance knowledge on the importance of knowledge translation and advocacy

CanMEDS roles

  1. Communicator
  2. Leader
  3. Health Advocate

Physician Practice Improvement – Gus Grant

Physician or learner assessment is an inexact process, fraught with bias and often made in reliance on inadequate data. It is incumbent on the medical regulator to make high stakes and defensible decisions regarding a physician’s fitness to practice. This talk will outline the perspective of a medical regulator regarding our profession’s approach to assessment.

At the end of this session, participants will be able to:

  1. flaws that persist in assessment at many levels of our medical system
  2. the regulator’s perspective on physician assessment
  3. how each of you might help

CanMEDS roles

  1. Communicator
  2. Collaborator
  3. Leader
  4. Professional

Antiphospholipid Syndrome – Michelle Petri

Antiphospholipid antibodies occur at a low frequency in the general population. When they occur at high titer and are persistent, they confer a risk of hypercoagulability. The most important antibody is the lupus anticoagulant. Treatment of APS thrombosis is with warfarin (not DOACs). Hydroxychloroquine can be used for primary prevention.

At the end of this session, participants will be able to:

  1. recognize the presentations of the catastrophic form of catastrophic APS
  2. consider the role of prophylactic therapy in patients with persistently positive lupus anticoagulant
  3. discuss the concerns about DOACs in APS management

CanMEDS roles

  1. Scholar
  2. Professional
  3. Medical Expert

Inflammatory Myopathies: Dermatomyositis, Polymyositis and Beyond – Pari Basharat

Overview of the classification, clinical signs and symptoms and treatment of different sub-types of myositis.

At the end of this session, participants will be able to:

  1. review the clinical signs and symptoms of myositis, including atypical presentations
  2. review the laboratory findings associated with myositis and briefly review the pathology of inflammatory myopathies
  3. review of treatment strategies

CanMEDS roles

  1. Medical Expert
  2. Scholar

Severe Lupus: Be Afraid of the Big Bad Wolf  – Evelyne Vinet

Through case discussions, we will review the treatment of refractory lupus nephritis, as well as the management of 2 acute and life-threatening conditions associated with systemic lupus erythematosus.

At the end of this session, participants will be able to:

  1. apply evidence-based data to treat refractory lupus nephritis
  2. identify and manage two acute and life-threatening complications of systemic lupus erythematosus
  3. recognize predictors of adverse outcomes in severe systemic lupus erythematosus

CanMEDS roles

  1. Medical Expert
  2. Scholar

Juvenile Dermatomyositis: New Developments and Changes in Research Approaches – Adam Huber

This session will include discussion of new developments in the assessment and management of children with juvenile dermatomyositis. It will also consider changes in research approaches that are expected to facilitate progress in the study of this rare illness.

At the end of this session, participants will be able to:

  1. recognize presentations of juvenile dermatomyositis
  2. be aware of new developments in the diagnosis and management of juvenile dermatomyositis
  3. recognize challenges in the study of juvenile dermatomyositis and potential approaches to address these challenges

CanMEDS roles

  1. Medical Expert
  2. Scholar

Advancing Early Identification of Axial Spondyloarthritis: Development, Implementation and Evaluation of a Novel Inter-professional Model of Care – Laura Passalent

This session will provide an overview of the development, implementation and evaluation of an innovative inter-professional model of care for the early detection of axial spondyloarthritis.

At the end of this session, participants will be able to:

  1. describe the essential elements required to implement a novel model of care in the context of inflammatory arthritis
  2. identify key components beneficial to the evaluation of a novel model of care for inflammatory arthritis
  3. reflect on the clinician’s role in facilitating health system change

CanMEDS roles

  1. Collaborator
  2. Leader
  3. Health Advocate

Educating for Equity (E4E): A Framework to Build Social and Cultural Confidence in Providing Care – Lynden Crowshoe

The elements of the E4E Framework, an evidence-based approach to re-centering relationships and engaging with Indigenous patient social realities, will be discussed during this session.

At the end of this session, participants will be able to:

  1. discuss how colonization, inequity and adverse life experiences act as contributors to health outcomes for Indigenous populations
  2. explore how culture can be a facilitator of the clinical relationship and patient capacity
  3. consider and learn new approaches to re-centering relationships with Indigenous patients

CanMEDS roles

  1. Collaborator
  2. Health Advocate
  3. Professional

Friday, March 1, 2019

Benefits and Pitfalls of Current Biomarkers – Gilles Boire

Biomarkers bring order into clinical chaos, giving important clues to adapt treatment.  Biomarkers do not stand for disease and may in some cases give rise to major mistakes, unless the full clinical evaluation is appreciated.

At the end of this session, participants will be able to:

  1. illustrate using real patient presentations how biomarkers may be useful for patient care
  2. illustrate using real patient presentations how biomarkers should be interpreted in the clinical context
  3. list conditions that may induce false positivity in immune biomarkers

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Scholar

Neurology and Rheumatology MDT Working – Mark Roberts

Cross disciplinary working between Neurology and Rheumatology is vital to secure the diagnosis in patients with no relevant family history, presenting with myopathy. A ‘joint’ assessment approach is recommended and the importance of Neurophysiology, Muscle pathology, and genetics is emphasized.

At the end of this session, participants will be able to:

  1. identify that idiopathic fibromyalgia in men is rare
  2. recognize that rhabdomyolysis is commonly due to a rare metabolic disorder
  3. understand the causes of Limb Girdle Weakness are protean, and MDT approach and increasingly use of next generation genetics are required for diagnosis

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Scholar
  4. Professional

Hot topics in Spondyloarthritis – Michel Zummer

This session will address approach to management of SpA including a special focus on GI issues.

At the end of this session, participants will be able to:

  1. discuss the utility of fecal calprotectin (FCP) measurement
  2. consider the value of FCP in individuals with SpA

CanMEDS roles

  1. Medical Expert
  2. Communicator
  3. Collaborator

Vasculitis – Christian Pagnoux

Review some recent updates on the main adult vasculitides (GCA and ANCA vasculitis): review some of the ongoing and coming trials in vasculitis; and understand how CanVasc tries to contribute to the management of your patients with vasculitis, and help you in your practice.

At the end of this session, participants will be able to:

  1. review recent updates on the main adult vasculitides (GCA and ANCA vasculitis)
  2. review ongoing and coming trials in vasculitis
  3. understand how CanVasc tries to contribute to the management of your patients with vasculitis, and help you in your practice

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Leader
  4. Health Advocate
  5. Scholar

Giving Effective Coaching Feedback for Competence by Design – Anna Oswald

We will briefly review the rationale and key changes for Competence by Design and then will focus on strategies for giving effective coaching feedback.

At the end of this session, participants will be able to:

  1. identify and practice strategies to give effective coaching feedback and avoid common pitfalls
  2. differentiate coaching/formative feedback (assessment for learning) vs judging/summative feedback (assessment of learning)
  3. implement strategies that will facilitate efficient clinical observation

CanMEDS roles

  1. Scholar

Wombatology: Bridging Reproduction and Rheumatic Disease – Carl Laskin

Cases will be presented dealing with the assessment and management of reproductive issues in patients with a rheumatic disease.

At the end of this session, participants will be able to:

  1. formulate an approach to the assessment of a patient with a rheumatic disease contemplating a pregnancy
  2. identify risk factors in rheumatic disease patients contemplating a pregnancy
  3. formulate a management plan for a pregnant woman with a rheumatic disease

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Professional

Understanding the Spectrum of Joint Hypermobility Syndromes. Ehlers Danlos Syndromes and Beyond – Roberto Mendoza

Joint hypermobility can be an appreciated feature for some individuals. But when its associated to tissue fragility and recurrent dislocations can lead to significant morbidity. The session will help you recognize conditions to consider when assessing a patient with hypermobility.

At the end of this session, participants will be able to:

  1. list the manifestations of EDS that go beyond the musculoskeletal and dermatological systems
  2. recognize the 2017 revised diagnostic criteria of EDS and put them in the context of new knowledge concerning connective tissue disorders
  3. demonstrate an understanding of the known genetic basis of EDS and describe how rare types of EDS inform more common connective tissue disorders.

CanMEDS roles

  1. Medical Expert
  2. Health Advocate
  3. Scholar

Research 101: What to Know to Get the Most Out of it – Sabrina Cavallo &  Karine Toupin-April

This workshop will provide an overview of the various methods used in clinical rheumatology research;
describe ways by which health care providers can get involved in rheumatology research; and help health care providers think of how they can get involved in rheumatology research.

At the end of this session, participants will be able to:

  1. describe the various methods used in clinical rheumatology research
  2. describe ways by which they can get involved in rheumatology research
  3. make a plan to get involved in rheumatology research

CanMEDS roles

  1. Medical Expert
  2. Leader
  3. Scholar

Why Infections are Still Nothing to Sneeze at: Vaccine Recommendations for Patients with Rheumatic Disease – Shirley Lake & Michael Libman

The incidence and burden of vaccine-preventable diseases are high in patients with rheumatologic disease. Our patient population is increasingly complex with underlying chronic conditions and immunosuppressive medications. Keeping them protected from vaccine-preventable infections is challenging: we need to know not only what vaccines are recommended, but to understand when best to administer these vaccines.

At the end of this session, participants will be able to:

  1. explain the burden and impact of illness on patients with rheumatic diseases and on the health care system
  2. review, through cases and examples, vaccine recommendations in rheumatic disease patients
  3. share successful initiatives to support immunization programs and optimize vaccine uptake in rheumatic disease patients

CanMEDS roles

  1. Medical Expert
  2. Communicator
  3. Collaborator
  4. Health Advocate

Creating Safer Spaces: The Bridging of Transgender and Rheumatological Care – Herbert Bonifacio

The workshop will highlight the psycho-social and medical approaches to transgender care and how such considerations may be implemented into your rheumatological clinical setting and practice.

At the end of this session, participants will be able to:

  1. recognize the psycho-social and medical approaches towards gender dysphoria and the research supporting each approach
  2. integrate considerations of psycho-social and medical management of gender dysphoria into your patient’s rheumatological care plan
  3. appraise your clinical practice for inclusivity towards patients with gender dysphoria

CanMEDS roles

  1. Medical Expert
  2. Communicator
  3. Collaborator

Saturday, March 2, 2019

Vasculitis – Christian Pagnoux

Review some recent updates on the main adult vasculitides (GCA and ANCA vasculitis): review some of the ongoing and coming trials in vasculitis; and understand how CanVasc tries to contribute to the management of your patients with vasculitis, and help you in your practice.

At the end of this session, participants will be able to:

  1. review recent updates on the main adult vasculitides (GCA and ANCA vasculitis)
  2. review ongoing and coming trials in vasculitis
  3. understand how CanVasc tries to contribute to the management of your patients with vasculitis, and help you in your practice

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Leader
  4. Health Advocate
  5. Scholar

Scleroderma – There is Treatment! You Need to Know About It – Janet Pope

Bridge the gap in knowledge for contemporary treatment in scleroderma. Awareness of screening and treatment for various organs will be reinforced. This will be interactive and case based.

At the end of this session, participants will be able to:

  1. improve your screening in patients with scleroderma for treatable organ involvement
  2. update your treatment in scleroderma
  3. consider where new data from trials will be used in your practice when following patients with scleroderma

CanMEDS roles

  1. Medical Expert
  2. Communicator
  3. Health Advocate
  4. Scholar
  5. Professional

Rheumatic Consequences of Cancer Immunotherapy: The Tip of a Giant Iceberg. Implications for the Rheumatologist – Clifton Bingham

Immune Checkpoint Inhibitors are growing in use for various cancers but cause immune-related adverse events affecting multiple organs including rheumatic syndromes. Treating rheumatic IRAEs may require immunosuppression, which may impact anti-tumor responses.

At the end of this session, participants will be able to:

  1. recognize the spectrum of rheumatologic immune-related adverse events (IRAEs) associated with cancer immunotherapy
  2. differentiate features of rheumatologic IRAEs from “traditional” rheumatic diseases
  3. develop an approach to treatment for rheumatologic IRAEs in collaboration with oncologists

CanMEDS roles

  1. Medical Expert
  2. Collaborator

See No Evil; Hear No Evil; Speak No Evil: Having an Informed, Positive Biosimilar Transition Conversation with your Patient – Cheryl Koehn, Sasha Bernatsky & John Esdaile

This workshop will model the development of a patient-HCP conversation about controlled transitions to biosimilars.

At the end of this session, participants will be able to:

  1. understand the unintended effects health care professional language and beliefs have on their patients when discussing policy transitioning from a biologic originator to a biologic biosimilar
  2. engage in role playing biologic policy transition conversations with inflammatory arthritis patients
  3. understand how to explain the principles of biosimilars and the rationale for biosimilars policy transition in a manner that is sensitive to patient safety and efficacy concerns and need for evidence based information

CanMEDS roles

  1. Communicator
  2. Collaborator
  3. Leader
  4. Scholar

Snap, Crackle, Pop: Office-Based Treatments for Common Lower Extremity Sport Injuries – Claire LeBlanc & Elie Wakim

We will review 3 injured athletes and learn how to manage each condition clinically including the roles for physiotherapy and bracing.

At the end of this session, participants will be able to:

  1. be familiar with medical management of specific knee and ankle injuries
  2. understand the physiotherapists role in the management of these conditions
  3. be familiar with the indications for bracing in the management of these injuries

CanMEDS roles

  1. Medical Expert
  2. Collaborator

Global Health Issues Relevant to Paediatric Rheumatology – Mercedes Chan

This workshop will highlight emerging issues in global health as they relate to pediatric rheumatology training and practice.

At the end of this session, participants will be able to list 3 global health phenomena and describe their relevance to pediatric rheumatology care in Canada.

CanMEDS roles

  1. Medical Expert
  2. Communicator
  3. Collaborator
  4. Leader
  5. Health Advocate
  6. Scholar
  7. Professional

Building a Registry: Bridging Data from Patients, Physicians and other Sources of Information

This session will be interactive. Demonstration of a model of registry implementable in daily practice.  Demonstration of interconnection with EMR and reasons to participate in these initiatives.

At the end of this session, participants will be able to:

  1. understand the advantages to use and participate in collecting data
  2. understand the benefit from data collection for the physicians, patients and community

CanMEDS roles

  1. Communicator
  2. Collaborator
  3. Leader
  4. Scholar
  5. Professional

The CRA-AAC-CIHR-CATCH Collaborative Project to “Build an Economic Business Case for AAC IA Models of Care” – Elena Lopatina, Deborah Marshall & Carter Thorne

An interactive workshop will provide participants with an overview of the 4-way partnership between CRA, AAC, CIHR and CATCH Cohort-an exploratory project aiming to identify the factors that contribute to a successful model of care in the Canadian environment.

At the end of this session, participants will be able to:

  1. confirm the purpose and why we need to build an Economic Business Case for IA Models of Care in Canada
  2. identify the role of the Cost-consequence analysis of IA MOCs and how it can contribute to identifying opportunities to improve access to care, and ultimately patient outcomes
  3. determine value and strength of collaborative research.

CanMEDS roles

  1. Collaborator
  2. Scholar

Ultrasound Pearls for Adult Rheumatologists (registration limited to 12) – Alessandra Bruns

Ultrasound hands-on in order to show extra-articular aspects of Psoriatic Arthritis and the anatomic aspects of the subtalar joint in RA.

At the end of this session, participants will be able to:

  1. review the sonoanatomy of the non-articular structures mostly involved in PsA
  2. review the sonoanatomy of the subtler joint and sinus tarsi in RA patients

CanMEDS roles

  1. Medical Expert
  2. Scholar